Medscape Gastroenterology> Hepatology Highlights Rowen K. Zetterman, MD May 18, 2018 A Problem Increasing in Size Nonalcoholic fatty liver disease (NAFLD) is a condition of hepatic steatosis without significant alcohol intake or another identifiable secondary cause that would result in fat accumulation within hepatocytes. NAFLD is associated with obesity, type 2 diabetes mellitus, and/or hyperlipidemia.[1] Patients with obesity […]
Tag Archives: Liver
Alpha-lipoic acid research Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway Min AK, Kim MK, Seo HY, Kim HS, Jang BK, Hwang JS, Choi HS, Lee KU, Park KG, Lee IK.Biochem Biophys Res Commun. 2010 Mar 12;393(3):536-41. Epub 2010 Feb 12. Accumulating evidence suggests that plasminogen activator inhibitor (PAI)-1 […]
Roughly 40 Million Americans are at an Increased Risk for Liver Diseases. People Who are Obese, Those With Hepatitis C, People Taking Medications that Damage the Liver, and Those Exposed to High Levels of Environmental Toxins May be More Likely to Get Liver Diseases. Liver Diseases Statistics 1 in 10 Americans are affected by liver […]